Industry Supported Symposium IV

Industry Supported Symposium

Addressing Current Questions and Emerging Considerations with the Use of PARP Inhibitors in the Management of Ovarian Cancer

CME Provided by Research to Practice; this symposium is supported by AbbVie Inc., AstraZeneca Pharmaceuticals LP, Clovis Oncology and TESARO. CE is not offered by SGO.


  • Neil Love, MD, Research to Practice, Miami, FL


  • Kathleen N. Moore, MD, University of Oklahoma, Oklahoma City, OK
  • Robert L. Coleman, MD, The University of Texas MD Anderson Cancer Center, Houston, TX
  • Jonathan Ledermann, MD, UCL Cancer Institute at University College London, London, UK
  • Amit M. Oza, MD, University Health Network, Toronto, Canada

Location: Kalakaua A

Registration Link: